Moximed, Inc. is focused on developing joint-preserving solutions for patients suffering from knee osteoarthritis. The company's primary product, the Atlas System, functions as an implantable joint unloader, similar to a shock absorber, specifically targeting individuals experiencing pain in the medial compartment of the knee. This innovative approach aims to alleviate joint pain, reduce dynamic load, and potentially delay the necessity for more invasive surgical interventions. Moximed seeks to enhance the standard of care for osteoarthritis patients, helping them maintain an active lifestyle while serving both patients and medical professionals globally. Established in 2006 and headquartered in Hayward, California, Moximed was previously known as ExploraMed NC4, Inc.
Private Equity Round in 2021
80/20 is a world-class originator and manufacturer of aluminum T-slotted building systems for various applications and end-markets. 80/20 provides T-slot aluminum profiles, or bars, that have channels used to connect other bars and parts — for instance, panels, linear bearings, or casters. It is a building system anyone can use to create custom solutions.
SetPoint Medical Corporation, a clinical-stage bioelectronic medicine company, develops implantable neuromodulation devices for treating patients with debilitating inflammatory diseases. SetPoint Medical Corporation was formerly known as Innovative Metabolics Inc. and changed its name to SetPoint Medical Corporation in July 2008. The company was incorporated in 2006 and is based in Valencia, California.
DecoArt is a manufacturer, marketer and supplier of acrylic paints and craft supplies.
Waterfront Brands Waterfront Brands offers a complete line-up of premium brands across its divisions. Waterfront manufactures and distribute to dealers and distributors around North America,
MSHS Group consistently provides turnkey solutions for the Maritime, Oil & Gas and Stationary Power Industries.
Relievant Medsystems, Inc. is a medical device company focused on developing innovative treatments for chronic axial low back pain. The company's primary offering is the Intracept procedure, which targets the basivertebral nerve to relieve vertebrogenic low back pain through a minimally invasive approach. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional development and operations office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic options that enhance the quality of life for patients suffering from this prevalent condition.
Teel Plastics is a manufacturer of custom extruded plastic tubing and profiles.
SetPoint Medical Corporation, a clinical-stage bioelectronic medicine company, develops implantable neuromodulation devices for treating patients with debilitating inflammatory diseases. SetPoint Medical Corporation was formerly known as Innovative Metabolics Inc. and changed its name to SetPoint Medical Corporation in July 2008. The company was incorporated in 2006 and is based in Valencia, California.
Private Equity Round in 2019
Garmat Usa, LLC designs and manufactures paint booths, finishing solutions, and related accessories for the large vehicles like Busses, RV’s and large commercial trucks, automotive collision repair, Marine, Aviation and industrial end markets. Garmat Usa, LLC serves its national, multi-site operator ("MSO") customers and independent repair shops through a nationwide distributor network. Garmat Usa, LLC was founded in 1988 and is headquartered in Englewood, Colorado.
Garmat Usa, LLC designs and manufactures paint booths, finishing solutions, and related accessories for the large vehicles like Busses, RV’s and large commercial trucks, automotive collision repair, Marine, Aviation and industrial end markets. Garmat Usa, LLC serves its national, multi-site operator ("MSO") customers and independent repair shops through a nationwide distributor network. Garmat Usa, LLC was founded in 1988 and is headquartered in Englewood, Colorado.
Cantrell is a manufacturer of equipment and systems for the poultry processing industry. Cantrell has earned a reputation for designing and delivering quality products and parts that meet the needs of the poultry processing industry. Among the products the company manufactures are evisceration and picking equipment, second processing equipment, wing segmenters, vacuum systems, and spare parts. Cantrell sells its products to leading poultry processors
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
NuoDB’s distributed SQL database for cloud applications helps customers get applications to market faster and reduce their total cost of ownership. Software vendors and e-commerce companies rely on NuoDB to obtain the combination of scale-out simplicity, elasticity, and continuous availability that cloud applications require, with the transactional consistency and durability that databases of record demand.
As a result, customers can capitalize on modern technologies such as cloud computing and containerization to ensure their applications are ready for today’s evolving expectations, as well as any future requirements.
NuoDB is headquartered in Cambridge, Massachusetts, USA, with offices in Dublin, London, and Sofia.
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.
Olympic Ophthalmics is a medical device company developing novel treatments for dry eye disease. The company’s focus is to develop devices to treat the signs and symptoms of Dry Eye Disease (DED). It works by stimulating the trigeminal parasympathetic pathway to activate the glands responsible for tear film production. Olympic Ophthalmics was founded in 2017 by Michael Gertner and is based in Issaquah, Washington.
Private Equity Round in 2017
Bettcher Industries is an ISO 9001-certified, vertically integrated manufacturing corporation with a worldwide customer base. The company is a leading developer and maker of innovative equipment for food processing, foodservice, industrial, medical and other operations. Established in 1944, Bettcher Industries brings more than seven decades of successful innovation to the market.
SetPoint Medical Corporation, a clinical-stage bioelectronic medicine company, develops implantable neuromodulation devices for treating patients with debilitating inflammatory diseases. SetPoint Medical Corporation was formerly known as Innovative Metabolics Inc. and changed its name to SetPoint Medical Corporation in July 2008. The company was incorporated in 2006 and is based in Valencia, California.
Safe Fuel Systems is a FAA/EASA Repair Facility which specializes in testing, repair, overhaul and modification of fuel systems, hydraulics and accessories for major domestic and international operators as well as military aircrafts.
Big Switch Networks Inc. specializes in data center networking technologies, catering to a global audience with solutions that enhance operational efficiency and business agility. Founded in 2010 and headquartered in Santa Clara, California, the company offers two primary products: Big Monitoring Fabric and Big Cloud Fabric. Big Monitoring Fabric functions as a network packet broker, enabling security chains for inline traffic and providing comprehensive visibility across the organization's entire network. Big Cloud Fabric employs open networking and software-defined networking technologies, supporting various environments such as VMware, OpenStack, and network function virtualization. The company's solutions facilitate improved visibility and security in multi-cloud and on-premises enterprise settings. Additionally, Big Switch Networks has formed strategic partnerships with major industry players, contributing to several open source communities to drive innovation in cloud-first networking.
Private Equity Round in 2017
DreamLine is a leading global manufacturer and distributor of high quality shower doors, tub doors, shower enclosures and acrylics shower bases. We are passionate about smart and visionary design delivering affordable luxury bathroom solutions to the bath and shower marketplace. They have achieved worldwide accolades for off-the-shelf and custom shower door solutions with sleek modern style and impressive value. We structure their company`s philosophy to ensure customer satisfaction, exceptional quality and overall excellence in their products and our team members. DreamLine has the ultimate solution for any shower project.
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.
Moximed, Inc. is focused on developing joint-preserving solutions for patients suffering from knee osteoarthritis. The company's primary product, the Atlas System, functions as an implantable joint unloader, similar to a shock absorber, specifically targeting individuals experiencing pain in the medial compartment of the knee. This innovative approach aims to alleviate joint pain, reduce dynamic load, and potentially delay the necessity for more invasive surgical interventions. Moximed seeks to enhance the standard of care for osteoarthritis patients, helping them maintain an active lifestyle while serving both patients and medical professionals globally. Established in 2006 and headquartered in Hayward, California, Moximed was previously known as ExploraMed NC4, Inc.
Relievant Medsystems, Inc. is a medical device company focused on developing innovative treatments for chronic axial low back pain. The company's primary offering is the Intracept procedure, which targets the basivertebral nerve to relieve vertebrogenic low back pain through a minimally invasive approach. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional development and operations office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic options that enhance the quality of life for patients suffering from this prevalent condition.
Miramar Labs develops medical devices for aesthetic indications that treat primary axillary (underarm) hyperhidrosis in adults. The miraDry System cannot be used to treat hyperhidrosis elsewhere on the body, including the hands and feet.
It was founded in 2006 and is based in Sunnyvale, California.
Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expertise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.
NuoDB’s distributed SQL database for cloud applications helps customers get applications to market faster and reduce their total cost of ownership. Software vendors and e-commerce companies rely on NuoDB to obtain the combination of scale-out simplicity, elasticity, and continuous availability that cloud applications require, with the transactional consistency and durability that databases of record demand.
As a result, customers can capitalize on modern technologies such as cloud computing and containerization to ensure their applications are ready for today’s evolving expectations, as well as any future requirements.
NuoDB is headquartered in Cambridge, Massachusetts, USA, with offices in Dublin, London, and Sofia.
Big Switch Networks Inc. specializes in data center networking technologies, catering to a global audience with solutions that enhance operational efficiency and business agility. Founded in 2010 and headquartered in Santa Clara, California, the company offers two primary products: Big Monitoring Fabric and Big Cloud Fabric. Big Monitoring Fabric functions as a network packet broker, enabling security chains for inline traffic and providing comprehensive visibility across the organization's entire network. Big Cloud Fabric employs open networking and software-defined networking technologies, supporting various environments such as VMware, OpenStack, and network function virtualization. The company's solutions facilitate improved visibility and security in multi-cloud and on-premises enterprise settings. Additionally, Big Switch Networks has formed strategic partnerships with major industry players, contributing to several open source communities to drive innovation in cloud-first networking.
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.
Adara, the global leader in permissioned data and verified identity, combines the power of global data consortiums to inform its 1 billion digital identities with over 22 billion data elements across 130 countries and serving Global 2,000 customers. Whether informing digital marketing, programmatic advertising, search, identity and verification, or stopping fraud, Adara provides you with more customers, less friction, and better outcomes. For more information, visit us at www.ADARA.com.
SetPoint Medical Corporation, a clinical-stage bioelectronic medicine company, develops implantable neuromodulation devices for treating patients with debilitating inflammatory diseases. SetPoint Medical Corporation was formerly known as Innovative Metabolics Inc. and changed its name to SetPoint Medical Corporation in July 2008. The company was incorporated in 2006 and is based in Valencia, California.
Kona Medical is committed to alleviating the suffering and health risks associated with drug-resistant hypertension with a more effective, less invasive approach to renal artery denervation. The company was founded in 2009 by Michael Gertner, MD, with seed financing from Essex Woodlands. Kona was formed on the basis of combining Dr. Gertner’s inventions in the field with the assets of Therus Corporation, a predecessor company in the field of therapeutic focused ultrasound.
Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.
Ra Pharma is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma is leveraging its ability to rapidly generate drug candidates to develop its own portfolio of products and partnerships focused on intracellular protein-protein interactions and other innovative approaches to addressing unmet medical needs.
It was founded in 2008 and headquartered in Cambridge, Massachusetts.
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.
Galleon Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and markets treatments for sleep apnea and related breathing control disorders. It offers GAL-021, a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients and patients with sleep apnea; GLN- 21,160, an oral development candidate for sleep apnea; and GAL-044, a small molecule used as a preventative medicine for surgical pain. The company was founded in 2003 and is based in Horsham, Pennsylvania.
MuleSoft, Inc. is a provider of the Anypoint Platform, a cloud-based application integration solution that enables organizations to connect their applications, data, and devices. Founded in 2006 and headquartered in San Francisco, California, MuleSoft facilitates the creation of application networks through its flexible platform, which utilizes APIs to enable seamless communication between various systems and applications, whether cloud-based or on-premises. The platform allows customers to build reusable components, simplifying the integration process and promoting business agility. MuleSoft has established a strategic alliance with IQVIA and operates as a subsidiary of Salesforce.
Moximed, Inc. is focused on developing joint-preserving solutions for patients suffering from knee osteoarthritis. The company's primary product, the Atlas System, functions as an implantable joint unloader, similar to a shock absorber, specifically targeting individuals experiencing pain in the medial compartment of the knee. This innovative approach aims to alleviate joint pain, reduce dynamic load, and potentially delay the necessity for more invasive surgical interventions. Moximed seeks to enhance the standard of care for osteoarthritis patients, helping them maintain an active lifestyle while serving both patients and medical professionals globally. Established in 2006 and headquartered in Hayward, California, Moximed was previously known as ExploraMed NC4, Inc.
Twelve manufactures medical devices. It was formerly known as Foundry Newco XII, Inc. The company was incorporated in 2009 and is based in Menlo Park, California.
NuoDB’s distributed SQL database for cloud applications helps customers get applications to market faster and reduce their total cost of ownership. Software vendors and e-commerce companies rely on NuoDB to obtain the combination of scale-out simplicity, elasticity, and continuous availability that cloud applications require, with the transactional consistency and durability that databases of record demand.
As a result, customers can capitalize on modern technologies such as cloud computing and containerization to ensure their applications are ready for today’s evolving expectations, as well as any future requirements.
NuoDB is headquartered in Cambridge, Massachusetts, USA, with offices in Dublin, London, and Sofia.
dlhBOWLES manufactures and markets plastic air and fluid handling assemblies, tubing, hoses, and profile extrusions. It offers injection molded thermoplastic parts, design and engineering services, precision injection molding, washer system tubing assemblies, air and fluid management, extruded thermoplastic tubes and profiles, rapid prototyping, and lab testing and design of experiments for process. dlhBOWLES was formerly known as DLH Industries, Inc. and changed its name to dlhBOWLES in July 2015. The company was founded in 1975 and is based in Canton, Ohio. dlhBOWLES operates as a subsidiary of Bowles Fluidics Corporation.
Sunlight Aerospace is a technology development company based in South Plainfield, New Jersey, specializing in advanced solar unmanned aerial vehicles (UAVs). The company focuses on creating fleets of solar UAVs, known as Sunfleets, which feature innovative airframe designs, lightweight photovoltaic systems, and advanced formation flight control. These UAVs are engineered for high-altitude, long-endurance missions, serving as platforms for new airborne communication networks that provide wireless broadband and internet services. In addition to UAV development, Sunlight Aerospace also offers communication networks and custom firmware and software for managing flight control, power management, and communications. Their solar UAVs have diverse applications, including wireless communications, precision agriculture, land surveys, and monitoring for wildfires and wildlife, as well as border patrol operations. Founded in 2007, Sunlight Aerospace is dedicated to advancing the field of airborne wireless communication technology.
Socrata is the market leader in making existing government data discoverable, usable, and actionable for government workers and the people they serve. Socrata provides a data-as-a-service data platform and cloud applications exclusively for city, county, state, and federal government organizations.
Socrata delivers unprecedented, data-driven innovation and cost-savings by bringing together disparate systems and leveraging the cloud to dramatically enhance the effectiveness of government programs, to improve quality of life for residents, positively impact local economies, and achieve excellence in government operations. Socrata solutions are designed and developed to meet strict government standards. The technology is optimized on the Amazon Web Services (AWS) Public Sector cloud and delivered using the exclusive Socrata Blueprint Methodology. Socrata has earned Federal Risk and Authorization Management Program (FedRAMP) Authority to Operate (ATO).
Miramar Labs develops medical devices for aesthetic indications that treat primary axillary (underarm) hyperhidrosis in adults. The miraDry System cannot be used to treat hyperhidrosis elsewhere on the body, including the hands and feet.
It was founded in 2006 and is based in Sunnyvale, California.
Ivantis Inc. is dedicated to developing innovative treatments for primary open angle glaucoma, a condition affecting over 60 million people globally. The company has created an intracanalicular scaffold or implantable device designed to alleviate high intraocular pressure in patients, offering a less invasive and more effective therapeutic option. Founded in 2007 and based in Irvine, California, Ivantis also provides a Session Persistence Server, which safeguards telnet task workers against data loss due to network issues and ensures terminal emulation users maintain productivity across various devices and operating systems. As Ivantis advances its glaucoma treatment solutions, it aims to expand its focus to other debilitating ophthalmic diseases. The company primarily serves ophthalmology specialists in the United States, providing its solutions for use in clinical trials.
Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.
ForSight Labs is focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. Our environment is creative and collaborative; a place where entrepreneurs and investors work together to drive innovative technologies through concept, development, and ultimately commercialization in high-impact eye care companies (ForSight VISION companies). Each day millions of people rely on their vision and suffer when it is lost. There are few disabilities as impactful to quality of life as the loss of vision. The number of people with impaired vision in the US, including blindness, is expected to more than double over the next three decades. Recent estimates of the cost of vision loss in the US exceed $50 billion dollars annually. ForSight Labs brings together highly motivated and capable team members, clinicians and investors focused on starting and sustaining efforts to deliver innovative solutions to the ophthalmic community and the patients it serves.
ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs. ForSight VISION5 is developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy. The company is currently in its second Phase 2 clinical study for its lead product, the Helios insert.
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.
MuleSoft, Inc. is a provider of the Anypoint Platform, a cloud-based application integration solution that enables organizations to connect their applications, data, and devices. Founded in 2006 and headquartered in San Francisco, California, MuleSoft facilitates the creation of application networks through its flexible platform, which utilizes APIs to enable seamless communication between various systems and applications, whether cloud-based or on-premises. The platform allows customers to build reusable components, simplifying the integration process and promoting business agility. MuleSoft has established a strategic alliance with IQVIA and operates as a subsidiary of Salesforce.
NuoDB’s distributed SQL database for cloud applications helps customers get applications to market faster and reduce their total cost of ownership. Software vendors and e-commerce companies rely on NuoDB to obtain the combination of scale-out simplicity, elasticity, and continuous availability that cloud applications require, with the transactional consistency and durability that databases of record demand.
As a result, customers can capitalize on modern technologies such as cloud computing and containerization to ensure their applications are ready for today’s evolving expectations, as well as any future requirements.
NuoDB is headquartered in Cambridge, Massachusetts, USA, with offices in Dublin, London, and Sofia.
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.
HealthLoop, Inc. operates a SaaS platform that enables medical practices to monitor signs and symptoms, and communicate with patients during the recovery process. Its platform enables doctors to identify patients at risk of decline in the follow up period. The company’s platform also collects patients’ feedbacks and monitors status against expected progress; and sends alerts to physicians or providers about patients who are at risk of treatment failures, complications, or hospital readmissions. It serves medical offices in the United States. HealthLoop, Inc. was founded in 2009 and is based in Moffett Field, California.
Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to discovering and developing small molecule therapeutics for cancer treatment. The company focuses on targeting tumor metabolism and tumor immunology to create innovative anti-cancer drugs. Its lead product candidate, CB-839, is an inhibitor of glutaminase currently undergoing Phase II clinical trials for solid tumors. Additionally, Calithera is developing CB-1158, an oral arginase inhibitor in Phase I/II trials for hematology and oncology indications. The company is also working on other candidates, including CB-280 for cystic fibrosis and CB-708, an inhibitor of CD73. Calithera has established collaborations with major pharmaceutical firms, including Bristol-Myers Squibb and Incyte Corporation, to advance its research and development efforts. Founded in 2010, Calithera aims to address critical challenges in cancer therapy through its specialized drug development pipeline.
PeopleMatter, Inc. is a workforce management platform that specializes in talent management software designed to enhance the performance of service-industry brands. Founded in 2001 and based in Charleston, South Carolina, the company provides solutions tailored for various sectors, including technology, transportation, healthcare, government, biotech, and recreation. PeopleMatter offers a comprehensive hire-to-retire system that simplifies the hiring process for hourly and shift workers, enabling managers to source, screen, and onboard employees more efficiently. By streamlining applicant tracking and onboarding, the platform aims to reduce friction in recruiting and improve overall efficiency, engagement, and customer satisfaction within the service industry. In June 2016, PeopleMatter was acquired by Snagajob.
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California. Founded in 2005, it provides a practice management software platform that includes features such as charting, scheduling, billing, e-Prescribing, lab integrations, and secure messaging. The platform aims to connect a wide range of stakeholders in the healthcare ecosystem, including medical professionals, patients, labs, billers, imaging centers, and life science partners. Additionally, Practice Fusion offers Practice Fusion Insight, a healthcare database designed for medical professionals. The company serves a diverse clientele, including independent practices, small and large medical groups, community organizations, and non-profits. In 2018, Practice Fusion became a subsidiary of Allscripts Healthcare Solutions, further enhancing its capabilities in the electronic health records space.
Convo provides an enterprise social collaboration platform that enables easy, secure conversations between desk/non-desk workers to accelerate company productivity and engagement. Unlike existing email-focused or chat-centric collaboration platforms, only Convo combines the ease of social networks with rich collaboration capabilities to simplify and optimize work interactions for all employees -- no email required.
Mint Bills is an application that enables its users to set reminders to pay bills. It utilizes proprietary account aggregation technology for secure payment technologies in its mobile applications. Mint Bills' primary service allows users to pay bills and track bank, credit card, investment, and loan transactions and balances through a provided mobile application. It currently has applications for iOS and Android platforms.
SetPoint Medical Corporation, a clinical-stage bioelectronic medicine company, develops implantable neuromodulation devices for treating patients with debilitating inflammatory diseases. SetPoint Medical Corporation was formerly known as Innovative Metabolics Inc. and changed its name to SetPoint Medical Corporation in July 2008. The company was incorporated in 2006 and is based in Valencia, California.
Socrata is the market leader in making existing government data discoverable, usable, and actionable for government workers and the people they serve. Socrata provides a data-as-a-service data platform and cloud applications exclusively for city, county, state, and federal government organizations.
Socrata delivers unprecedented, data-driven innovation and cost-savings by bringing together disparate systems and leveraging the cloud to dramatically enhance the effectiveness of government programs, to improve quality of life for residents, positively impact local economies, and achieve excellence in government operations. Socrata solutions are designed and developed to meet strict government standards. The technology is optimized on the Amazon Web Services (AWS) Public Sector cloud and delivered using the exclusive Socrata Blueprint Methodology. Socrata has earned Federal Risk and Authorization Management Program (FedRAMP) Authority to Operate (ATO).
ForSight Labs is focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. Our environment is creative and collaborative; a place where entrepreneurs and investors work together to drive innovative technologies through concept, development, and ultimately commercialization in high-impact eye care companies (ForSight VISION companies). Each day millions of people rely on their vision and suffer when it is lost. There are few disabilities as impactful to quality of life as the loss of vision. The number of people with impaired vision in the US, including blindness, is expected to more than double over the next three decades. Recent estimates of the cost of vision loss in the US exceed $50 billion dollars annually. ForSight Labs brings together highly motivated and capable team members, clinicians and investors focused on starting and sustaining efforts to deliver innovative solutions to the ophthalmic community and the patients it serves.
Automatic's mission is to empower drivers with knowledge about themselves and their cars so they can be safer and drive smarter. Automatic believes that drivers should not have to buy a new car to have a better driving experience, and that the phone in their pocket can bring the future of driving to today's automobiles. Automatic is based in San Francisco, California, but its team comes from every corner of the world. The team obsesses about creating beautiful and well-engineered products that make a real difference in people's lives. Its members are big on ideas, low on ego, and love working together.
Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expertise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.
Scioderm, LLC researches, develops, and manufactures drugs for the treatment of patients with epidermolysis bullosa (EB). It offers Zorblisa, an investigational therapy for the treatment of skin blistering and lesions associated with EB, a rare group of inherited disorders that manifest as blistering or erosion of the skin, and the epithelial lining of other organs. The company’s Zorblisa facilitates the healing of skin lesions and reduction of the incidence and/or severity of new lesions. The company was founded in 2012 and is based in Durham, North Carolina. As of September 30, 2015, Scioderm, LLC operates as a subsidiary of Amicus Therapeutics, Inc.
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.
MuleSoft, Inc. is a provider of the Anypoint Platform, a cloud-based application integration solution that enables organizations to connect their applications, data, and devices. Founded in 2006 and headquartered in San Francisco, California, MuleSoft facilitates the creation of application networks through its flexible platform, which utilizes APIs to enable seamless communication between various systems and applications, whether cloud-based or on-premises. The platform allows customers to build reusable components, simplifying the integration process and promoting business agility. MuleSoft has established a strategic alliance with IQVIA and operates as a subsidiary of Salesforce.
Catalyst Biosciences is a drug discovery and development company. It is creating novel catalytic biopharmaceutical products based on engineered human proteases. The mission is to establish protease therapeutics as a new therapeutic platform comparable in depth and scope to antibody pharmaceuticals. The Company is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation.
Founded in 1997, the company is headquartered in South San Francisco, California.
PeopleMatter, Inc. is a workforce management platform that specializes in talent management software designed to enhance the performance of service-industry brands. Founded in 2001 and based in Charleston, South Carolina, the company provides solutions tailored for various sectors, including technology, transportation, healthcare, government, biotech, and recreation. PeopleMatter offers a comprehensive hire-to-retire system that simplifies the hiring process for hourly and shift workers, enabling managers to source, screen, and onboard employees more efficiently. By streamlining applicant tracking and onboarding, the platform aims to reduce friction in recruiting and improve overall efficiency, engagement, and customer satisfaction within the service industry. In June 2016, PeopleMatter was acquired by Snagajob.
Adara, the global leader in permissioned data and verified identity, combines the power of global data consortiums to inform its 1 billion digital identities with over 22 billion data elements across 130 countries and serving Global 2,000 customers. Whether informing digital marketing, programmatic advertising, search, identity and verification, or stopping fraud, Adara provides you with more customers, less friction, and better outcomes. For more information, visit us at www.ADARA.com.
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
Private Equity Round in 2013
OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.
R2 Semiconductor, Inc., a power management company, provides low-voltage transistors. It offers FasTrack for envelope tracking; FastLane that optimizes power management for multi-core applications processors and digital System on Chips (SoCs); and SoC to integrate power management. The company was founded in 2008 and is based in Sunnyvale, California.
Now known as [SalesforceIQ](https://www.crunchbase.com/organization/salesforceiq), RelateIQ, a salesforce.com company, has re-thought customer relationship management from the ground up, building the world's first Relationship Intelligence platform. It automatically captures data on your most important sales prospects, making it easy to collaborate with your teammates to close deals faster. The platform works everywhere you work, whether it's on a mobile app in your pocket or in your email inbox through a browser extension, and advanced data science capabilities mean RelateIQ will provide the insights you need before you even realize you need them. RelateIQ helps our customers drive more revenue and save hours of time, all while making their jobs less work. For more information on how RelateIQ is changing the way the world works, please connect with us on Facebook, LinkedIn, or Twitter.
Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to discovering and developing small molecule therapeutics for cancer treatment. The company focuses on targeting tumor metabolism and tumor immunology to create innovative anti-cancer drugs. Its lead product candidate, CB-839, is an inhibitor of glutaminase currently undergoing Phase II clinical trials for solid tumors. Additionally, Calithera is developing CB-1158, an oral arginase inhibitor in Phase I/II trials for hematology and oncology indications. The company is also working on other candidates, including CB-280 for cystic fibrosis and CB-708, an inhibitor of CD73. Calithera has established collaborations with major pharmaceutical firms, including Bristol-Myers Squibb and Incyte Corporation, to advance its research and development efforts. Founded in 2010, Calithera aims to address critical challenges in cancer therapy through its specialized drug development pipeline.
Kona Medical is committed to alleviating the suffering and health risks associated with drug-resistant hypertension with a more effective, less invasive approach to renal artery denervation. The company was founded in 2009 by Michael Gertner, MD, with seed financing from Essex Woodlands. Kona was formed on the basis of combining Dr. Gertner’s inventions in the field with the assets of Therus Corporation, a predecessor company in the field of therapeutic focused ultrasound.
Big Switch Networks Inc. specializes in data center networking technologies, catering to a global audience with solutions that enhance operational efficiency and business agility. Founded in 2010 and headquartered in Santa Clara, California, the company offers two primary products: Big Monitoring Fabric and Big Cloud Fabric. Big Monitoring Fabric functions as a network packet broker, enabling security chains for inline traffic and providing comprehensive visibility across the organization's entire network. Big Cloud Fabric employs open networking and software-defined networking technologies, supporting various environments such as VMware, OpenStack, and network function virtualization. The company's solutions facilitate improved visibility and security in multi-cloud and on-premises enterprise settings. Additionally, Big Switch Networks has formed strategic partnerships with major industry players, contributing to several open source communities to drive innovation in cloud-first networking.
Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.
Promedior, Inc. a clinical-stage biotechnology company, develops therapeutics to treat rare fibrotic diseases, such as myelofibrosis and idiopathic pulmonary fibrosis; and retinal fibrovascular diseases, such as age related macular degeneration and diabetic retinopathy. Its portfolio includes PRM-151, a recombinant form of human pentaxin-2 protein (rhPTX-2) formulated for intravenous injection; and PRM-167, a variant of rhPTX-2 developed for intravitreal delivery in retinal fibrovascular diseases. Promedior, Inc. was formerly known as Fibrotix, Inc. The company was incorporated in 2006 and is based in Lexington, Massachusetts. As of February 13, 2020, Promedior, Inc. operates as a subsidiary of Roche Holding AG.
Catalyst Biosciences is a drug discovery and development company. It is creating novel catalytic biopharmaceutical products based on engineered human proteases. The mission is to establish protease therapeutics as a new therapeutic platform comparable in depth and scope to antibody pharmaceuticals. The Company is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation.
Founded in 1997, the company is headquartered in South San Francisco, California.
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.
Doximity, founded in 2011 and based in San Francisco, is the largest professional medical network in the United States, with over 70 percent of all U.S. physicians as members. The platform is designed to enhance the productivity and success of medical professionals by facilitating communication among physicians, nurse practitioners, physician assistants, and registered nurses. Doximity enables its users to connect with colleagues and patients, while also providing a space to share insights on current healthcare trends and research. The company was established by the creators of Epocrates and Rock Health, further emphasizing its commitment to improving professional collaboration in the medical field.
ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs. ForSight VISION5 is developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy. The company is currently in its second Phase 2 clinical study for its lead product, the Helios insert.
Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.
Sonatype, Inc. specializes in software supply chain automation solutions aimed at enhancing the security and efficiency of software development. The company's flagship product, Nexus Lifecycle, enables organizations to manage the flow of software components by defining rules and policies. Additionally, Nexus Firewall protects against the introduction of risky components, while Nexus Auditor monitors applications in production to ensure ongoing compliance. The Nexus Repository serves as a platform for organizing, storing, and distributing software components, and Nexus Repository OSS facilitates caching of remote repositories to reduce latency. Sonatype caters to various industries, including finance, government, technology, insurance, healthcare, and manufacturing, and has established a strategic partnership with Fugue. Founded in 2008 and headquartered in Fulton, Maryland, Sonatype also maintains offices in McLean, Virginia; London, United Kingdom; and Sydney, Australia. The company's commitment to open source software development is evident in its contributions to projects like Apache Maven and the Central repository.
NuoDB’s distributed SQL database for cloud applications helps customers get applications to market faster and reduce their total cost of ownership. Software vendors and e-commerce companies rely on NuoDB to obtain the combination of scale-out simplicity, elasticity, and continuous availability that cloud applications require, with the transactional consistency and durability that databases of record demand.
As a result, customers can capitalize on modern technologies such as cloud computing and containerization to ensure their applications are ready for today’s evolving expectations, as well as any future requirements.
NuoDB is headquartered in Cambridge, Massachusetts, USA, with offices in Dublin, London, and Sofia.
Rhythm sells and serves video, rich media and other immersive advertising formats to connect brand advertisers with mobile audiences
With sharp designs, meticulous fit and a commitment to developing beautifully crafted basics in California, we’re refining the notion of modern workwear, one t-shirt at a time
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California. Founded in 2005, it provides a practice management software platform that includes features such as charting, scheduling, billing, e-Prescribing, lab integrations, and secure messaging. The platform aims to connect a wide range of stakeholders in the healthcare ecosystem, including medical professionals, patients, labs, billers, imaging centers, and life science partners. Additionally, Practice Fusion offers Practice Fusion Insight, a healthcare database designed for medical professionals. The company serves a diverse clientele, including independent practices, small and large medical groups, community organizations, and non-profits. In 2018, Practice Fusion became a subsidiary of Allscripts Healthcare Solutions, further enhancing its capabilities in the electronic health records space.
Twelve
Venture Round in 2012
Twelve manufactures medical devices. It was formerly known as Foundry Newco XII, Inc. The company was incorporated in 2009 and is based in Menlo Park, California.
Hownd, formerly known as LocBox, provides local businesses with effective marketing solutions designed to generate repeat customers and increase foot traffic. By offering a comprehensive Integrated Marketing product, Hownd enables businesses to manage campaigns across various channels—including email, social media, and text messaging—through a single dashboard. This approach helps local establishments, often lacking the expertise and resources for effective marketing, connect with their best customers in a timely and relevant manner. Hownd focuses on industries such as entertainment, health and beauty, and food and beverage, allowing these businesses to move away from generic marketing strategies that yield minimal results. With a growing client base that includes hundreds of businesses and franchises across the U.S., Hownd effectively manages millions of emails and social media interactions, empowering local owners to drive revenue and enhance customer engagement.
Kona Medical is committed to alleviating the suffering and health risks associated with drug-resistant hypertension with a more effective, less invasive approach to renal artery denervation. The company was founded in 2009 by Michael Gertner, MD, with seed financing from Essex Woodlands. Kona was formed on the basis of combining Dr. Gertner’s inventions in the field with the assets of Therus Corporation, a predecessor company in the field of therapeutic focused ultrasound.
MuleSoft, Inc. is a provider of the Anypoint Platform, a cloud-based application integration solution that enables organizations to connect their applications, data, and devices. Founded in 2006 and headquartered in San Francisco, California, MuleSoft facilitates the creation of application networks through its flexible platform, which utilizes APIs to enable seamless communication between various systems and applications, whether cloud-based or on-premises. The platform allows customers to build reusable components, simplifying the integration process and promoting business agility. MuleSoft has established a strategic alliance with IQVIA and operates as a subsidiary of Salesforce.
Relievant Medsystems, Inc. is a medical device company focused on developing innovative treatments for chronic axial low back pain. The company's primary offering is the Intracept procedure, which targets the basivertebral nerve to relieve vertebrogenic low back pain through a minimally invasive approach. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional development and operations office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic options that enhance the quality of life for patients suffering from this prevalent condition.
Promedior, Inc. a clinical-stage biotechnology company, develops therapeutics to treat rare fibrotic diseases, such as myelofibrosis and idiopathic pulmonary fibrosis; and retinal fibrovascular diseases, such as age related macular degeneration and diabetic retinopathy. Its portfolio includes PRM-151, a recombinant form of human pentaxin-2 protein (rhPTX-2) formulated for intravenous injection; and PRM-167, a variant of rhPTX-2 developed for intravitreal delivery in retinal fibrovascular diseases. Promedior, Inc. was formerly known as Fibrotix, Inc. The company was incorporated in 2006 and is based in Lexington, Massachusetts. As of February 13, 2020, Promedior, Inc. operates as a subsidiary of Roche Holding AG.
PeopleMatter, Inc. is a workforce management platform that specializes in talent management software designed to enhance the performance of service-industry brands. Founded in 2001 and based in Charleston, South Carolina, the company provides solutions tailored for various sectors, including technology, transportation, healthcare, government, biotech, and recreation. PeopleMatter offers a comprehensive hire-to-retire system that simplifies the hiring process for hourly and shift workers, enabling managers to source, screen, and onboard employees more efficiently. By streamlining applicant tracking and onboarding, the platform aims to reduce friction in recruiting and improve overall efficiency, engagement, and customer satisfaction within the service industry. In June 2016, PeopleMatter was acquired by Snagajob.
R2 Semiconductor, Inc., a power management company, provides low-voltage transistors. It offers FasTrack for envelope tracking; FastLane that optimizes power management for multi-core applications processors and digital System on Chips (SoCs); and SoC to integrate power management. The company was founded in 2008 and is based in Sunnyvale, California.